fintepla
ucb pharma s.a. - fenfluramine hydrochloride - epilepsies, myoclonic - antiepileptics, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.
namuscla
lupin europe gmbh - mexiletine hydrochloride - myotonic lidelser - hjertetapi - namuscla er indikert for symptomatisk behandling av myotonia hos voksne pasienter med ikke-dystrophic myotonic lidelser.
brintellix
h. lundbeck a/s - vortioxetine - depressiv lidelse, major - psychoanaleptics, - behandling av alvorlige depressive episoder hos voksne.
duloxetine lilly
eli lilly nederland b.v. - duloksetin - neuralgia; diabetic neuropathies; depressive disorder, major - psychoanaleptics, - duloxetine lilly er indisert hos voksne:behandling av depressive disordertreatment av diabetiker perifer nevropatisk paintreatment av generell angst disorderduloxetine lilly er indisert hos voksne.
tramadol actavis 50 mg
actavis group ptc ehf - tramadolhydroklorid - kapsel, hard - 50 mg
tralieve vet 80 mg
dechra regulatory b.v. - tramadolhydroklorid - tyggetablett - 80 mg
tralieve vet 20 mg
dechra regulatory b.v. - tramadolhydroklorid - tyggetablett - 20 mg
nobligan 50 mg
grünenthal gmbh - tramadolhydroklorid - kapsel, hard - 50 mg
nobligan retard 100 mg
grünenthal gmbh - tramadolhydroklorid - depottablett - 100 mg
nobligan retard 150 mg
grünenthal gmbh - tramadolhydroklorid - depottablett - 150 mg